Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q3 2024 · 10-Q
Revenue$36.06M$36.06M−49.5% vs Q3 2023 Net Income-$1.95M-$1.95MN/M vs Q3 2023 EPS Diluted-$0.03-$0.03— vs Q3 2023 Operating Income-$7,092,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,952,000N/M Margins · derivedOperating margin-19.7%−9.2 pt vs Q3 2023
Net margin-5.4%−5.8 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end